EcoDrugPlus

Histone Deacetylase 2

Ensembl ID : ENSCVAG00000004322
Gene Symbol: HDAC2
4 Cross references
205 Possible Orthologues:

Histone Deacetylase 3

Ensembl ID : ENSCVAG00000011733
Gene Symbol: HDAC3
4 Cross references
155 Possible Orthologues:

Histone Deacetylase 4

Ensembl ID : ENSCVAG00000003096
Gene Symbol: HDAC4
3 Cross references
196 Possible Orthologues:

Histone Deacetylase 4-Like

Ensembl ID : ENSCVAG00000006486
Gene Symbol: LOC107091035
3 Cross references
202 Possible Orthologues:

Histone Deacetylase 5

Ensembl ID : ENSCVAG00000010474
Gene Symbol: HDAC5
3 Cross references
196 Possible Orthologues:

Histone Deacetylase 7

Ensembl ID : ENSCVAG00000010539
Gene Symbol: HDAC7
2 Cross references
190 Possible Orthologues:

Histone Deacetylase 7-Like

Ensembl ID : ENSCVAG00000018349
Gene Symbol: LOC107103432
2 Cross references
197 Possible Orthologues:

Histone Deacetylase 8

Ensembl ID : ENSCVAG00000012998
Gene Symbol: HDAC8
3 Cross references
206 Possible Orthologues:

Hyperpolarization Activated Cyclic Nucleotide Gated Potassium Channel 4

Ensembl ID : ENSCVAG00000008202
Gene Symbol: HCN4
3 Cross references
210 Possible Orthologues:

Hyperpolarization Activated Cyclic Nucleotide Gated Potassium Channel 4

Ensembl ID : ENSCVAG00000018886
Gene Symbol: HCN4
3 Cross references
219 Possible Orthologues:

Hypocretin Receptor 2

Ensembl ID : ENSCVAG00000019834
Gene Symbol: HCRTR2
3 Cross references
201 Possible Orthologues:

Ileal Sodium/bile Acid Cotransporter-Like

Ensembl ID : ENSCVAG00000008525
Gene Symbol: LOC107082484
3 Cross references
210 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).